News

Women with a certain type of breast cancer whose tumors have a favorable gene-expression profile may be able to safely avoid chemotherapy without an increased risk of recurrence, a new study has found.

The PD-1 inhibitor pembrolizumab (Keytruda) was approved by the FDA today for patients with pretreated advanced non–small cell lung cancer (NSCLC) across all histologies whose tumors express PD-L1.

Little is known about the potential benefits of adjuvant radiotherapy in older women diagnosed with triple-negative breast cancer (TNBC), but findings of a retrospective study reported at the 2015 Breast Cancer Symposium suggest that the approach may be worth considering for this population.

The FDA has approved the combination of nivolumab (Opdivo) and ipilimumab (Yervoy) as a treatment for patients with BRAF V600 wild-type unresectable or metastatic melanoma

Children exposed to residential pesticides are at a higher risk of developing pediatric hematopoietic cancers, a new study has found.

LLS Closes Blood Cancer Awareness Month by Celebrating Impact of our Investment in Lifesaving Research – Helping to Make Someday, Today, for Blood Cancer Patients

Chemotherapy in young women can damage ovaries and result in premature menopause, but new research shows that the addition of hormonal treatment may preserve ovarian function and fertility in patients with breast cancer and may increase the chances of pregnancy after treatment.

USPSTF issues draft recommendations.

SPOHNC is pleased to introduce EmergingMed's Clinical Trial Navigation Service. We want you to be aware of all of your treatment options. SPOHNC has partnered with EmergingMed to offer you a way to take action.

The Bladder Cancer Advocacy Network (BCAN) and Paradigm today announced a partnership for the launch of a large-scale genomically-driven bladder cancer study. The Hoosier Cancer Research Network (HCRN) will act as the coordinating center.

Rolapitant (Varubi), which was recently approved by the FDA, has been shown to significantly reduce delayed phase CINV when used in combination with other antiemetic agents.

The Patient Access Network (PAN) Foundation launched a new patient assistance program for Medicare patients being treated for heart failure.

Regardless of insurance status, patients with multiple myeloma can expect financial hardships-even those making over $100,000 a year, according to a study published online in Lancet Haematology.

The oral nucleoside TAS-102 (Lonsurf) received FDA approval today for the treatment of patients with advanced colorectal cancer (CRC) who are not responding to other treatments.

In the past 12 months, women have been more likely to have seen their primary physician, dentist, eye doctor, and hairdresser than their OBGYN, according to results of a new survey.

A practical solution may be topical lidocaine application.

The surgeon who performed my first surgery, a total colectomy and left oophorectomy had no personality. He was always very serious and didn't fill me with any warm fuzzy feelings.

A study to test the effects of the Mediterranean diet on the prevention of cardiovascular disease yielded an unexpected result-the Mediterranean diet supplemented with extra virgin olive oil (EVOO) lowered the risk of breast cancer in older women by 68%.

Amy Hansen was diagnosed with Ovarian cancer while pregnant at 12 weeks. Amy's son, Gavin Michael, was born in 2013.

A new study has found that nonbiological factors including marital status, county-level income, and insurance status may also affect the chances of survival among young patients with acute myelogenous leukemia (AML).

The US Preventive Services Task Force issued a draft guideline today recommending the use of low-dose aspirin for certain individuals for the prevention of CRC and cardiovascular disease.

The day came when I looked in the mirror and I didn't like what I saw. Here I was 5"7', and tipping the scales at 225 lbs. I was asking myself, "What on earth can I do about this?"

The day after the 14th anniversary of the September 11 terrorist attacks, Richard Funcheon gazed at One World Trade Center along New York City's skyline as he stood in line at Liberty State Park waiting to get his caricature drawn.

My dad was diagnosed with Stage 4 lung cancer in February of 2014. His diagnosis included the BRAF mutation, which is still in the process of being researched for successful treatments.

Hot flashes are severe, daily nuisances for many breast cancer survivors, but a few needle pricks from acupuncture may be enough to cool the unpleasant episodes, according to a new study published in the Journal of Clinical Oncology.

Incidence is rising, mainly because of successful treatment of first cancer.

For most families across the country, September is notable as the first full month back at school. September marks the end of carefree summer days and a return to routine: Packing lunches. Rushing out the door. Homework before dinner. Bedtime battles.

Emil Parente is a WMer with a real past, and he is happy to share it with others, particularly those who are newly diagnosed.

The FDA will review a new drug application for the oral agent uridine triacetate as a treatment for patients at risk of serious toxicity following an overdose of 5-fluorouracil (5-FU) or are exhibiting symptoms of serious toxicity within 96 hours of 5-FU administration.

The American Psychosocial Oncology Society (APOS) partnered with Yale School of Nursing to launch the Screening for Psychosocial Distress Program in 2014.